The global alopecia market is expected to reach over USD 11.8 Billion by 2024
according to a new report published by Grand View Research, Inc. The increased
healthcare expenditure and the resultant augmentation of healthcare facilities,
globally, are the key drivers of the alopecia treatment market.
Additionally, the increasing awareness
amongst individuals pertaining to the availability of the treatment options can
be attributed to the favorable initiatives taken by organizations such as the
National Alopecia Areata Foundation (NAAF) and the American Hair Loss
Association. The increasing R&D investments pertaining to the development
of novel therapeutics for the treatment of alopecia is expected to boost the
usage rates.
International
conferences are held by the NAAF for individuals suffering from alopecia,
irrespective of their age, furthermore, NAAF also promotes research by bringing
together scientists from all over the world. The 31st National Conference of NAAF will be held in
Washington DC from 14th July to 16th July, 2016.
The FDA approval of the Janus kinase
inhibitors (JAK) drugs that stimulate the growth of hair follicles with minimal
side effects is further expected to boost the alopecia treatment market. The
Children Alopecia Project by AHLA is dedicated towards making investments in
Children Support Groups, which provide funding for children who cannot afford
to attend the NAAF Conference and promote research and development activities
in alopecia treatment for children.
Bald Truth is a radio program that is
involved in spreading awareness about the different types of alopecia affecting
people and about the varied products used for the effective treatment of
alopecia that are currently available in the market. Rapunzel Project is
another initiative by AHLA that is dedicated towards preventing hair loss in
chemotherapy patients.
Full research report on alopecia market analysis:
http://www.grandviewresearch.com/industry-analysis/alopecia-market
http://www.grandviewresearch.com/industry-analysis/alopecia-market
Further key findings from the study suggest:
·
In 2015, topical treatment accounted for
over USD 2.8 billion in global alopecia treatment market. The key factors
responsible for the large share of topical products include easy application,
non-invasive nature, and high awareness amongst the population pertaining to
the available therapeutics. The top brands of topical solution are Keranique,
Phytoworx, Ultrax, and Nioxin.
·
The patent expiration of majority of the
drugs, such as Propecia & Rogaine and the FDA approval gained for the JAK
drugs, in 2015, which is an immunosuppresant with minimal side effects are
expected to boost the alopecia treatment market during the forecast period.
·
In 2015, the dominant gender segment for
the alopecia market were women that generated a revenue of about USD 4.03
billion and is expected to grow at a lucrativerate over the forecast period.
The increasing awareness amongst women about alopecia and the emphasis laid
upon appearance by them,are the key drivers of this segment.
·
North America was the highest revenue
generating region with the market valued at over USD 2.49 billion in 2015. The
increasing number of consumer disposable incomes, the introduction of new
drugs, and the favorable initiatives taken by the pertinent organizations
namely, NAAF and AHLA, are the key factors for the region’s large share.
·
Key players operating in the market are
Cipla, Merck & Co., Johnson & Johnson, Lifes2good, Dr. Reddy’s
Laboratories, Sun Pharma, Kirkland Signature, Alpecin, Vitabiotics, and Phyto
Ales Group.
View
more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global alopecia market on the
basis of treatment and gender:
Global alopecia treatment outlook, by
revenue (USD Million, 2016 - 2024)
·
Oral
·
Topical
·
Others
Global alopecia gender outlook, by revenue
(USD Million, 2016 - 2024)
·
Men
·
Women
Global alopecia regional outlook, by
revenue (USD Million, 2016 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
View Press Release of this research
report by Grand View Research: https://www.grandviewresearch.com/press-release/global-alopecia-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
